Molecular characterization of clinical varicella-zoster strains from India and differentiation from the Oka vaccine strain

Japanese Journal of Infectious Diseases

Volumn 61, Issue 1, 2008, Pages 65-67

  Kaushik, Karishma S ^a   Lahiri, Kunal K ^a   Chumber, Sushil K ^a,b   Gupta, Rajiv M ^a   Kumar, Satish ^a   Kapila, Ketoki ^a   Karade, Santosh ^a  

^a ARMED FORCES MEDICAL COLLEGE   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE;

ARTICLE; CHICKENPOX; GENOTYPE; HERPES ZOSTER; HUMAN; INDIA; NONHUMAN; OPEN READING FRAME; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION SITE; TYPE STRAIN; VACCINATION; VARICELLA ZOSTER VIRUS; VIRUS STRAIN; WILD TYPE;

CHICKENPOX; CHICKENPOX VACCINE; GENOTYPE; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; INDIA; MOLECULAR SEQUENCE DATA; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 40349096508     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Whitley, R.J. (1995): Varicella-zoster virus. p. 1345-1347. In G.L. Mandell, J.E.. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 4th ed. Churchill Livingstone, New York, NY.
2. Guess, H., Broughton, D., Melton, L., et al (1986): Population based studies of varicella complications. Pediatrics, 78, 723-727.
3. Takahashi, M., Otsuka, T. and Okuno, Y. (1974): Live vaccine used to prevent the spread of varicella in children in hospital. Lancet, 2, 1288-1290.
4. Krause, P. and Klinman, D. (1995): Efficacy, immunogenicity, safety and use of live attenuated chicken pox vaccine. J. Pediatr., 127, 518-525.
5. Gershon, A., LaRussa, P., Hardy, I., et al. (1992): Varicella vaccine: the American experience. J. Infect. Dis., 166, S63-S68.
6. Asano, Y, Suga, S., Yoshikawa, T., et al. (1994): Twenty-year follow up of protective immunity of the Oka strain live varicella vaccine. Pediatrics, 94, 524- 526.
7. Shiraki, K., Horiuchi, K., Asano, Y., et al. (1991): Differentiation of Oka varicella vaccine strain from wild varicella-zostrr virus strains isolated from vaccines and household contacts. J. Med. Virol., 33, 128-132.
8. Sharrar, R., LaRussa, P., Galea, S., et al. (2001): The postmarketing safety profile of varicella vaccine. Vaccine, 19, 916-923.
9. Davison, A. and Scott, J. (1986): The complete DNA sequence of the vancella-zoster virus. J. Gen. Virol., 67, 1759-1816.
10. Mori, C., Takahara, R., Toriyama, T., et al. (1998): Identification of the Oka strain of the live attenuated varicella vaccine from other clinical isolates by molecular epidemiologic analysis. J. Infect. Dis., 178, 35-38.
11. Sauerbrei, A., Eichhorn, U., Gawellek, S., et al. (2003): Molecular characterization of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain. J. Med. Virol., 71, 313-319.
12. LaRussa, P., Lungu, O., Hardy, I., et al. (1992): Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild type varicella zoster virus isolates. J. Virol., 66, 1016-1020.
13. Loparev, V., Agraw, T., Krause, P., et al. (2000): Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J. Clin. Microbiol., 38, 3156-3160.
14. Loparev, V, Martro, E., Rubtcova, E., et al. (2007): Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J. Clin. Microbiol., 45, 559-563.
15. LaRussa, P., Steinberg, S., Arvin, A., et al, (1998): Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J. Infect. Dis., 178 (Suppl. 1), S64-S66.
16. Hawrami, K., Hart, L., Pereira, F, et al. (1997): Molecular epedemiology of varicella-zoster virus in east London, England, between 1971 and 1995. J. Chn. Microbiol., 35,2807-2809.
17. Quinlivan, M., Hawrami, K., Barrett-Muir, W., et al. (2002): The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation, J. Infect. Dis., 186, 888-8S4.
18. Loparev, V., Gonzalez, A., Deleon-Carnes, M., et al. (2004): Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J. Virol., 78,8349-8358.
19. Dutta, A. and Parthasarthy, A. (2001): Varicella vaccine. p. 49. In IAP Guide Book on Immunization. Indian Academy of Pediatrics. CBS Publishers, New Delhi.
20. Takada, M., Suzutani, T., Asano, Y, et al. (1995): Identification of varicella-zoster virus strains by PCR analysis of three repeat elements and a PstI-site-less region. J. Ctin. Microbiol., 33, 658-660.
21. Quinlivan, M., Gershon, A., Steinberg, S., et al. (2005): An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus. J. Med. Virol., 75, 174-180.
22. Parker, S., Quinlivan, M., Taha, Y., et al., (2006): Genotyping of varicella-zostcr virus and the discrimination of OKA vaccine strains by TaqMan real-time PCR. J. Clin. Microbiol., 44, 3911-3914.
23. Loparev, V., McCaustland, K., Holloway, B., et al. (2000): Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes. J. Clin. Microbiol, 38, 4315-4319.